Phagenesis is hosting the Phagenesis Symposium on Post-Stroke-Dysphagia at the DSG 2026 conference in Berlin on September 10, 2026.

Public source

Publisher name

Public post

Diese Woche ist es soweit – DSG 2026 in Berlin. 🙌 Besonders freue ich mich auf unser Phagenesis Symposium zur Post-Stroke-Dysphagie am Donnerstag. Vier spannende Perspe…

Log in to read the full post

Company

Phagenesis

Retrain The Brain. Restore Swallowing Control.

Industry
Medical Device
Location
Manchester, GB
Company size
51–200 employees

About Phagenesis

Phagenyx® is the first and only clinically validated neuromodulation system that utilizes pharyngeal electrical stimulation (PES) to improve swallowing safety and efficiency to accelerate recovery from post-stroke dysphagia. Supported by 30+ publications and designed for real-world care, Phagenyx enables early intervention, resulting in a 6-day faster return to oral nutrition, >2x improvement in swallowing safety, and 8 fewer days in the hospital.

See more

Latest activity

4 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.